Capitol Biologics is a new venture from BioFactura, a company founded in 2004 that excels at small-scale biologics development and manufacturing.
Capitol Biologics is a full service CDMO supporting the R&D and early phase clinical trial manufacturing needs of emerging biotech firms. Focus is on quality-driven biologic, protein, & monoclonal antibody drug development from cell line development to GMP manufacturing.
Extensive Analytical and Quality Control capabilities to assess CQAs, ensuring seamless product development from conception to clinical readiness.
Proven track record in biologics development & manufacturing
Cutting-edge single-use technology & scalable platforms
Deployment of next-gen Continuous Manufacturing Processes
Fit for Purpose: By our nature, we are problem solvers.
Our aim is to efficiently deliver what you need, when you need it.
Since 2004, Capitol Biologics has evolved from a small-scale development lab into a full-service CDMO supporting early phase clinical trials.
Highly skilled staff in all areas required to develop and manufacture high quality and regulatory compliant biologics